amikacin has been researched along with Shock, Septic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cömert, B; Ergan, B; Ergün, B; Esenkaya, F; Gökmen, AN; Hanci, V; Heybeli, C; Küçük, M; Uzun, Ö; Yakar, MN | 1 |
| Annaert, P; De Winter, S; Desmet, S; Dreesen, E; Meersseman, W; Peetermans, W; Spriet, I; Van den Eede, N; van Hest, R; Vanbrabant, P; Verelst, S; Wauters, J | 1 |
| Boix Boix, AS; Brandariz Núñez, D; Gurri Hernand, FJ; Hernández Corredoira, V; Puig Forcada, J; Rodríguez Pedreira, P | 1 |
| Béraud, G; Iba Ba, J; Legout, L; Mouton, Y; Senneville, E; Yazdanpanah, Y | 1 |
| Baudrand, H; Devouassoux, G; Freymond, N; Marcu, M; Mbatchou Ngahane, BH; Pacheco, Y | 1 |
| De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
| de Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P | 1 |
| Benslama, A; Charra, B; Hachimi, A; Motaouakkil, S | 1 |
| Dhanarajani, PJ; Zeitoun, IM | 1 |
| Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P | 1 |
| Bouvet, O; Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Fabre, D; Galtier, M; Kinowski, JM; Saissi, G | 1 |
| Baranger, B; Brinquin, L; Fangio, P; Petitjeans, F; Rouquette-Vincenti, I; Szymczyszyn, P; Villevieille, T | 1 |
| Holloway, WJ | 1 |
| Artigas, A; Brunelli, L; Ferrer, R; Goma, G; Navas, A; Pastorelli, R; Ribas Ripoll, V; Romay, E | 1 |
1 review(s) available for amikacin and Shock, Septic
| Article | Year |
|---|---|
Cervical cellulitis and mediastinitis caused by odontogenic infections: report of two cases and review of literature.
Topics: Adult; Amikacin; Fatal Outcome; Focal Infection, Dental; Humans; Ludwig's Angina; Male; Mediastinal Emphysema; Mediastinitis; Metronidazole; Multiple Organ Failure; Retropharyngeal Abscess; Shock, Septic | 1995 |
3 trial(s) available for amikacin and Shock, Septic
| Article | Year |
|---|---|
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Prospective Studies; Sepsis; Shock, Septic; Tissue Distribution | 2021 |
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Belgium; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Shock, Septic | 2010 |
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic | 1993 |
10 other study(ies) available for amikacin and Shock, Septic
| Article | Year |
|---|---|
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis.
Topics: Acute Kidney Injury; Amikacin; Colistin; Critical Illness; Humans; Intensive Care Units; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic | 2023 |
[Septic shock secondary to Elizabethkingia meningoseptica: A case report].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Chryseobacterium; Drug Therapy, Combination; Flavobacteriaceae Infections; Humans; Male; Meropenem; Rifampin; Shock, Septic; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
[Primary Salmonella vascular graft infection and conservative treatment].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Cefotaxime; Ceftriaxone; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Femoral Artery; Humans; Laparotomy; Male; Ofloxacin; Oxacillin; Popliteal Artery; Prosthesis-Related Infections; Recurrence; Salmonella Infections; Salmonella typhimurium; Shock, Septic | 2008 |
[Lung abscess due to community acquired Klebsiella pneumonia].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Community-Acquired Infections; Comorbidity; Diabetes Mellitus; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Abscess; Male; Middle Aged; Piperacillin; Radiography, Thoracic; Shock, Septic; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Enterobacteriaceae; Female; Fluorescence Polarization Immunoassay; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Plasma; Pseudomonas aeruginosa; Renal Replacement Therapy; Shock, Septic | 2011 |
[Intrathecal use of amikacin and colistin].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Amikacin; Brain Ischemia; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Hydrocephalus; Injections, Spinal; Male; Meningitis, Bacterial; Pseudomonas Infections; Shock, Septic; Surgical Wound Infection; Ventriculostomy | 2008 |
Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration.
Topics: Adult; Aged; Amikacin; Body Weight; Ceftazidime; Critical Care; Drug Administration Schedule; Female; Hemofiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Organ Failure; Shock, Septic; Software | 1993 |
[Obesity, diabetes mellitus, and gas gangrene: a major therapeutic challenge].
Topics: Abscess; Amikacin; Anus Diseases; Buttocks; Candidiasis; Ceftazidime; Colostomy; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Fasciitis; Female; Gas Gangrene; Humans; Hyperbaric Oxygenation; Hypertension; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Complications; Shock, Septic; Vancomycin | 2001 |
Management of sepsis in the elderly.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Risk; Shock, Septic; Urinary Tract Infections | 1986 |
Metabolite analysis in sepsis through conditional independence maps.
Topics: Adult; Aged; Algorithms; Bayes Theorem; Biomarkers; Carnitine; Computer Graphics; Critical Care; Female; Humans; Intensive Care Units; Isoleucine; Length of Stay; Male; Markov Chains; Metabolomics; Middle Aged; Models, Statistical; Patient Discharge; Probability; Prospective Studies; Sepsis; Shock, Septic | 2015 |